Quadrant Biosciences Inc.
PrivateLast Round
Series B
Aug 8, 2023
Est. Valuation
$266.98M
Total Funding Raised
$10.55M
Company Overview
Quadrant Biosciences Inc. is a biotechnology company that develops epigenetic diagnostics for the early detection and diagnosis of neurological and developmental disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Telemedicine, Environmental Monitoring, Healthcare Analytics
Business Model
B2C
Customer Profile
Services & Consulting, Government Contracts, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Quadrant Biosciences Inc. Comparables
Compare Quadrant Biosciences Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cognoa | 78% | |
| MARAbio | 76% | |
| EarliPoint Health | 70% | |
Quadrant Biosciences Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 8, 2023 | ||||
| Crowdfunding | Aug 15, 2020 | ||||
| Debt | May 1, 2020 | ||||
| Debt | May 1, 2020 | ||||
| Grant | Jun 19, 2019 | ||||
Grant | Sep 19, 2018 |
Quadrant Biosciences Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| JPMorgan Chase & Co. | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2020
$756K round with J.P. Morgan
- May 1, 2020
$160K debt round completed.
Quadrant Biosciences Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Quadrant Biosciences Inc.'s valuation, stock price, and market status.